Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab

As of 28 October 2020, there are over 44 000 000 confirmed COVID-19 infections and over 1 000 000 deaths worldwide, including 945 367 infections and 45 765 deaths in the UK. Acute respiratory distress syndrome occurs in 50% of patients with secondary haemophagocytic lymphohistiocytosis, a hyperinfla...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Giorgio, Davies, Rebecca, Manfreda, Valeria Maria, Ul Abideen, Zain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798428/
https://www.ncbi.nlm.nih.gov/pubmed/33419750
http://dx.doi.org/10.1136/bcr-2020-238210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798428/
https://www.ncbi.nlm.nih.gov/pubmed/33419750
http://dx.doi.org/10.1136/bcr-2020-238210

Ejemplares similares